Acute Myelogenous Leukemia by Farhad Ravandi, Francis Giles (auth.), Judith E. Karp MD
By Farhad Ravandi, Francis Giles (auth.), Judith E. Karp MD (eds.)
Acute Myelogenous Leukemia is a well timed compilation of latest innovations within the molecular pathogenesis and molecular treatment of acute myelogenous leukemia (AML). the focal point is on chosen serious molecular determinants of AML pathogenesis and pathophysiology and the exploitation of those components via varied healing brokers and modalities. Bringing jointly new techniques and findings within the uncomplicated and medical technology of AML, the e-book emphasizes the molecular foundation for brand new cures that stand to have the best capability impression at the medical face of those ailments. The textual content offers insights into chosen novel thoughts at the moment and prospectively being constructed, together with interruption of particular sign transduction pathways, modulation of gene expression, makes an attempt to reinstate differentiation, and immunomodulation. there's an emphasis all through at the bidirectional move of data among the scientific and laboratory arenas, and either easy and scientific scientists will take advantage of this translational textual content.
Read Online or Download Acute Myelogenous Leukemia PDF
Similar nonfiction_9 books
This specified collection of studies summarizes present wisdom in all significant fields of crustacean neurobiology and all degrees in their CNS association, utilizing lobster and crayfish. It not just imparts theoretical wisdom but additionally describes all on hand modern and complicated suggestions, equivalent to patch clamp recordings, microelectrode concepts, immunocytochemistry and all tools of molecular genetics to spot mobile pathways of protein synthesis and peptidergic keep an eye on.
Elwyn Simons: A look for OriginsJohn G. Fleagle and Christopher C. Gilbert, EditorsFor approximately a part century, Dr. Elwyn Simons has ruled the learn of primate evolution. This quantity summarizes the present kingdom of information in lots of facets of primate and human evolution which were studied via Simons and his colleagues and areas it in a broader paleontological and old standpoint.
Content material: bankruptcy 1 creation: The Rational Use of Plasma Drug degrees in scientific drugs (pages 1–12): Louis LasagnaChapter 2 ideas of Pharmacokinetics (pages 13–33): Geoffrey T. TuckerChapter three Methodological Pitfalls: The impression of Experimental layout on effects (pages 35–49): Stephen H.
Explores the influence of the newest breakthroughs in cluster SIMS technologyCluster secondary ion mass spectrometry (SIMS) is a excessive spatial solution imaging mass spectrometry approach, that are used to symbolize the 3-dimensional chemical constitution in advanced natural and molecular platforms.
- New Trends in Atomic and Molecular Physics: Advanced Technological Applications
- Advances in 3D Geoinformation Systems
- Internal and External Aspects of Corporate Governance (Routledge Studies in Corporate Governance)
- Cytoskeleton and Human Disease
- The Rise of the Network Society: With a New Preface, Volume I, Second edition With a new preface
Extra info for Acute Myelogenous Leukemia
103. 104. 105. 106. 107. 108. 109. 110. 111. 19 20 PartI I Ravandi and Giles 112. Cortes J, Giles F, O'Brien S, et al. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders. Cancer 2003;97:2760-2766. 113. Kindler T, Breitenbuecher F, Marx A. Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia. Blood 2004;103(10):3644-3654. 114. Tse KF, Mukherjee G, Small D.
Disruption of the Cbfa2 gene causes necrosis and hemorrhaging in the central nervous system and blocks definitive hematopoiesis. Proc Nat! Acad Sci USA 1996;93:3444-3449. 9. Wang Q, Stacy T, Miller JD, et al. The CBF~ subunit is essential for CBFa2(AMLl) function in vivo. Cell 1996;87 :697-708. 10. Sasaki K, Yagi H, Bronson RT, et al. Absence offetalliver hematopoiesis in mice deficient in transcriptional coactivator core binding factor B, Proc Nat! Acad Sci USA 1996;93:12,359-12,363. 11. Niki M, Okada H, Takano H, et al.
Frank DA. STAT signaling in the pathogenesis and treatment of cancer. Mol Med 1999;5:432-456. scm 97. 98. 99. 100. 101. 102. 103. 104. 105. 106. 107. 108. 109. 110. 111. 19 20 PartI I Ravandi and Giles 112. Cortes J, Giles F, O'Brien S, et al. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders. Cancer 2003;97:2760-2766. 113. Kindler T, Breitenbuecher F, Marx A. Efficacy and safety of imatinib in adult patients with c-kit-positive acute myeloid leukemia.